Similar articles

• Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.

  Isaacs JD, Burrows N, Wing M, Keogan MT, Rebello PR, Watts RA, Pye RJ, Norris P, Hazelman BL, Hale G, Waldmann H. Isaacs JD, et al. Clin Exp Immunol. 1997 Nov;110(2):158-66. doi: 10.1111/j.1365-2249.1997.tb08312.x. Clin Exp Immunol. 1997. PMID: 9367397 Free PMC article.
• The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseases.

  Mariette X. Mariette X. Joint Bone Spine. 2004 Sep;71(5):357-60. doi: 10.1016/j.jbspin.2003.12.005. Joint Bone Spine. 2004. PMID: 15474382 Review. No abstract available.
• [New strategies in the immunotherapy of autoimmune diseases].

  Lorenz HM, Geiler T. Lorenz HM, et al. Dtsch Med Wochenschr. 2001 Sep 14;126(37):1023-8. doi: 10.1055/s-2001-17114. Dtsch Med Wochenschr. 2001. PMID: 11555778 Review. German. No abstract available.
• [Remicade in therapy of rheumatoid arthritis and Crohn diseases--no reason for panic].

  Kalden JR, Lochs H, Wollheim H. Kalden JR, et al. Z Rheumatol. 2002 Aug;61(4):466-8. doi: 10.1007/s00393-002-0401-y. Z Rheumatol. 2002. PMID: 12426854 German. No abstract available.
• Immunogenicity and autoimmunity during anti-TNF therapy.

  Atzeni F, Talotta R, Salaffi F, Cassinotti A, Varisco V, Battellino M, Ardizzone S, Pace F, Sarzi-Puttini P. Atzeni F, et al. Autoimmun Rev. 2013 May;12(7):703-8. doi: 10.1016/j.autrev.2012.10.021. Epub 2012 Nov 30. Autoimmun Rev. 2013. PMID: 23207283 Review.